Figure 3
Schematic representation of basic steps in lipogenesis and lipolysis in the adipocyte. To simplify the figure, only mechanisms
that are primary targets of maternal nutrition manipulation have been represented. Triacylglycerol (TG) circulates in blood
in the form of lipoproteins. Free fatty acids (FFA) that are released from lipoproteins, catalysed by lipoprotein lipase (LPL),
diffuse into the adipocyte. Intracellular FFA are converted to fatty acyl-CoA and are then re-esterified to form TG using
glycerol-3 phosphate (glycerol-3P) that is generated by glucose metabolism. FFA may also originate from acetyl-CoA (de novo lipogenesis) driven by the lipogenic enzymes acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS). Lipolysis occurs
via a cAMP-mediated cascade, which results in the phosphorylation of hormone-sensitive lipase (HSL), an enzyme that hydrolyzes
TG into FFA and glycerol. These FFA are then free to diffuse into the blood. Insulin enhances the storage of fat as TG by
increasing LPL and lipogenic enzyme activities. It also facilitates the transport of glucose by stimulating the GLUT4 glucose
transporter. In addition, phosphorylation and activation of cyclic nucleotide phosphodiesterases 3B (PDE3B) is a key event
in the antilipolytic action of insulin, decreasing cAMP levels in adipocytes. By contrast, leptin presents antilipogenic and
lipolytic effects by suppressing expression and activity of lipogenic enzymes and PPARG. Noradrenaline released from the sympathetic
autonomic nervous system binds β-adrenoreceptor (β-AR) and activates lipolysis. Prolonged exposure to glucocorticoids (GC)
that bind intracellular glucocorticoid receptor (GR) enhances adipogenesis. This may be due either to an increase in circulating
GC and/or to an increase in intracellular 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity that predominantly converts
inactive cortisone to active corticosterone, thus amplifying local GC action.